Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Affiliations

¹ Department of Medical Oncology, Gustave Roussy, Villejuif, France.
² Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
³ Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
⁴ Department of Pathology, Rennes Hospital and University, Rennes, France.
⁵ UCL Division of Surgery and Interventional Science, Royal Free Hospital, Specialist Center for Kidney Cancer, London, UK; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁶ Department of Clinical Oncology, Institute of Cancer Research, Royal Marsden Hospital, London, UK; Department of Medicine, University of Melbourne and Monash University, Victoria, Australia.
⁷ Internal Medicine (Tumour Research) and Clinic for Urology, West German Cancer Center, University Hospital Essen, Essen, Germany.
⁸ Division of Cancer Sciences, University of Manchester, Manchester; The Christie, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St. Gallen, Switzerland.
⁹ Department of Academic Radiotherapy, Institute of Cancer Research, Royal Marsden Hospital, Sutton Hospital, Sutton, UK.

Free article

Practice Guideline

B Escudier et al. Ann Oncol. 2019.

Free article

. 2019 May 1;30(5):706-720.

doi: 10.1093/annonc/mdz056.

¹ Department of Medical Oncology, Gustave Roussy, Villejuif, France.
² Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
³ Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
⁴ Department of Pathology, Rennes Hospital and University, Rennes, France.
⁵ UCL Division of Surgery and Interventional Science, Royal Free Hospital, Specialist Center for Kidney Cancer, London, UK; Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁶ Department of Clinical Oncology, Institute of Cancer Research, Royal Marsden Hospital, London, UK; Department of Medicine, University of Melbourne and Monash University, Victoria, Australia.
⁷ Internal Medicine (Tumour Research) and Clinic for Urology, West German Cancer Center, University Hospital Essen, Essen, Germany.
⁸ Division of Cancer Sciences, University of Manchester, Manchester; The Christie, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St. Gallen, Switzerland.
⁹ Department of Academic Radiotherapy, Institute of Cancer Research, Royal Marsden Hospital, Sutton Hospital, Sutton, UK.

No abstract available

Publication types